联系客服

002603 深市 以岭药业


首页 公告 以岭药业:首期股票期权与限制性股票激励计划草案(修订稿)

以岭药业:首期股票期权与限制性股票激励计划草案(修订稿)

公告日期:2013-05-06

                 石家庄以岭药业股份有限公司                     首期股票期权与限制性股票激励计划草案(修订稿)

                           证券简称:以岭药业                            证券代码:  002603 

                              石家庄以岭药业股份有限公司                              

                       首期股票期权与限制性股票激励计划                                     

                                           草案(修订稿)                  

                                                二〇一三年五月三日       

                                                         1

                 石家庄以岭药业股份有限公司                     首期股票期权与限制性股票激励计划草案(修订稿)

                     限制性股票激励计划:公司拟授予激励对象限制性股票,涉及的标的股票种类为               

                 人民币普通股,涉及的标的股票数量为1181.4万股;标的股票数量占当前以岭药业               

                 股本总数55250万股的比例为2.14%。其中首次授予1063.4万股,占本计划签署时公                 

                 司股本总额的1.92%;预留118万股,占限制性股票激励计划拟授予权益数量的               

                 9.99%,占本计划签署时公司股本总额的0.21%。           

                      3、预留部分的授予由董事会提出,监事会核实,公司在证监会指定信息披露网               

                 站对包括激励份额、激励对象职务、期权行权(限制性股票授予)价格等详细内容                  

                 做出充分的信息披露后,按中国证监会相关要求完成其他法定程序后进行授予。              

                      4、在激励计划公告当日至激励对象完成股票期权行权和限制性股票登记期间,               

                 若以岭药业发生资本公积转增股本、派发股票红利、股份拆细或缩股、配股等事宜,                 

                 股票期权和限制性股票数量及所涉及的标的股票总数将做相应调整。           

                     5、本激励计划首次授予的股票期权的行权价格为25.12元,限制性股票的授予价             

                 格为12.78元。在本激励计划公告当日至激励对象完成股票期权行权和限制性股票股              

                 份登记期间,若公司发生资本公积转增股本、派发股票红利、股份拆细或缩股、配               

                 股、派息等事宜,股票期权的行权价格和限制性股票的授予价格将做相应的调整。               

                     6、本激励计划有效期为股票期权和限制性股票授予之日起至所有股票期权行权             

                 或注销,和限制性股票解锁或回购注销完毕之日止。本激励计划有效期为自股票期权               

                 和限制性股票首次授予日起五年。      

                     7、以岭药业承诺不为激励对象依本激励计划获取有关股票期权或限制性股票提             

                 供贷款以及其他任何形式的财务资助,包括为其贷款提供担保。           

                     8、以岭药业承诺本激励计划经股东大会审议通过后30日内,公司不进行增发新                

                 股、资产注入、发行可转债等重大事项。          

                     9、本激励计划必须满足如下条件后方可实施:中国证券监督管理委员会备案无              

                 异议、以岭药业股东大会批准。      

                      10、自公司股东大会审议通过本激励计划之日起30日内,公司按相关规定召                

                 开董事会对激励对象进行授予,并完成登记、公告等相关程序。              

                      11、本次激励计划实施后,将不会导致股权分布不符合上市条件要求。               

                                                         3

                 石家庄以岭药业股份有限公司                     首期股票期权与限制性股票激励计划草案(修订稿)

                                                       目     录 

               第一章  释义......................................................................................................................................5

               第二章  激励计划的目的....................................................................................................................7

               第三章  激励计划的管理机构............................................................................................................7

               第四章  激励对象的确定依据和范围.................................................................................................8

                   一、激励对象的确定依据.............................................................................................................8

                   二、激励对象的范围....................................................................................................................8

                   三、激励对象的核实....................................................................................................................9

               第五章  激励计划的具体内容............................................................................................................9

                   一、股票期权激励计划................................................................................................................9

                   (一)标的股票来源..................................................................................................................10

                   (二)授出股票期权的数量和分配............................................................................................10

                   (三)股票期权的有效期、授权日、等待期和可行权日...........................................................10

                   (四)股票期权的行权价格及确定方法....................................................................................12

                   (五)激励对象的授权条件和行权条件.....................................................................................12

                   (六)股票期权激励计划的调整方法和程序..............................................................................15

                   (七)股票期权会计处理...........................................................................................................17

                   二、限制性股票激励计划..............................................................................